{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:14:08Z","timestamp":1790972048964,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,5,9]],"date-time":"2009-05-09T00:00:00Z","timestamp":1241827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00259-009-1154-5","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T09:50:30Z","timestamp":1241776230000},"page":"1565-1573","source":"Crossref","is-referenced-by-count":154,"title":["Initial results of hypoxia imaging using 1-\u03b1-d-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA)"],"prefix":"10.1007","volume":"36","author":[{"given":"Ernst J.","family":"Postema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J. B.","family":"McEwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence A.","family":"Riauka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dacia A.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas N.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard I.","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,9]]},"reference":[{"key":"1154_CR1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","volume":"93","author":"M H\u00f6ckel","year":"2001","unstructured":"H\u00f6ckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266\u201376. doi: 10.1093\/jnci\/93.4.266 .","journal-title":"J Natl Cancer Inst"},{"key":"1154_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-8140(93)90025-4","volume":"26","author":"M H\u00f6ckel","year":"1993","unstructured":"H\u00f6ckel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45\u201350. doi: 10.1016\/0167-8140(93)90025-4 .","journal-title":"Radiother Oncol"},{"key":"1154_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","volume":"38","author":"DM Brizel","year":"1997","unstructured":"Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285\u20139. doi: 10.1016\/S0360-3016(97)00101-6 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1154_CR4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0360-3016(96)00132-0","volume":"35","author":"M Nordsmark","year":"1996","unstructured":"Nordsmark M, Hoyer M, Keller J, Nielsen OS, Jensen OM, Overgaard J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1996;35:701\u20138. doi: 10.1016\/0360-3016(96)00132-0 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1154_CR5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.semnuclmed.2007.07.001","volume":"37","author":"ST Lee","year":"2007","unstructured":"Lee ST, Scott AM. Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole. Semin Nucl Med 2007;37:451\u201361. doi: 10.1053\/j.semnuclmed.2007.07.001 .","journal-title":"Semin Nucl Med"},{"key":"1154_CR6","first-page":"S209","volume":"27","author":"RC Urtasun","year":"1996","unstructured":"Urtasun RC, Parliament MB, McEwan AJ, Mercer JR, Mannan RH, Wiebe LI, et al. Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside. Br J Cancer Suppl 1996;27:S209\u201312.","journal-title":"Br J Cancer Suppl"},{"key":"1154_CR7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijrobp.2007.05.079","volume":"69","author":"AL Grosu","year":"2007","unstructured":"Grosu AL, Souvatzoglou M, R\u00f6per B, Dobritz M, Wiedenmann N, Jacob V, et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:541\u201351. doi: 10.1016\/j.ijrobp.2007.05.079 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"1154_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0167-8140(91)90181-F","volume":"20","author":"JD Chapman","year":"1991","unstructured":"Chapman JD. Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies. Radiother Oncol 1991;20(Suppl 1):13\u20139. doi: 10.1016\/0167-8140(91)90181-F .","journal-title":"Radiother Oncol"},{"key":"1154_CR9","first-page":"270","volume":"40","author":"LI Wiebe","year":"1996","unstructured":"Wiebe LI, Stypinski D. Pharmacokinetics of SPECT radiopharmaceuticals for imaging hypoxic tissues. Q J Nucl Med 1996;40:270\u201384.","journal-title":"Q J Nucl Med"},{"key":"1154_CR10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/028418600750013320","volume":"39","author":"L Bentzen","year":"2000","unstructured":"Bentzen L, Keiding S, Horsman MR, Falborg L, Hansen SB, Overgaard J. Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography \u2013 a study evaluating [18F]fluoro-2-deoxy-D-glucose. Acta Oncol 2000;39:629\u201337. doi: 10.1080\/028418600750013320 .","journal-title":"Acta Oncol"},{"key":"1154_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1099-1344(199901)42:1<3::AID-JLCR160>3.0.CO;2-H","volume":"42","author":"P Kumar","year":"1999","unstructured":"Kumar P, Stypinski D, Xia H, McEwan AJB, Machulla HJ, Wiebe LI. Fluoroazomycin arabinoside (FAZA): synthesis, 2H and 3H-labelling and preliminary biological evaluation of a novel 2-nitroimidazole marker of tissue hypoxia. J Label Comp Radiopharmaceuticals 1999;42:3\u201316. doi: 10.1002\/(SICI)1099-1344(199901)42:1<3::AID-JLCR160>3.0.CO;2-H .","journal-title":"J Label Comp Radiopharmaceuticals"},{"key":"1154_CR12","first-page":"106","volume":"46","author":"M Piert","year":"2005","unstructured":"Piert M, Machulla HJ, Picchio M, Reischl G, Ziegler S, Kumar P, et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. J Nucl Med 2005;46:106\u201313.","journal-title":"J Nucl Med"},{"key":"1154_CR13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0969-8051(02)00442-0","volume":"30","author":"D Sorger","year":"2003","unstructured":"Sorger D, Patt M, Kumar P, Wiebe LI, Barthel H, Seese A, et al. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 2003;30:317\u201326. doi: 10.1016\/S0969-8051(02)00442-0 .","journal-title":"Nucl Med Biol"},{"key":"1154_CR14","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/1078-0432.CCR-07-4995","volume":"14","author":"AM Spence","year":"2008","unstructured":"Spence AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, et al. Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res 2008;14:2623\u201330. doi: 10.1158\/1078-0432.CCR-07-4995 .","journal-title":"Clin Cancer Res"},{"key":"1154_CR15","first-page":"1851","volume":"45","author":"M Bruehlmeier","year":"2004","unstructured":"Bruehlmeier M, Roelcke U, Schubiger PA, Ametamey SM. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O. J Nucl Med 2004;45:1851\u20139.","journal-title":"J Nucl Med"},{"key":"1154_CR16","first-page":"410","volume":"47","author":"LM Cher","year":"2006","unstructured":"Cher LM, Murone C, Lawrentschuk N, Ramdave S, Papenfuss A, Hannah A, et al. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med 2006;47:410\u20138.","journal-title":"J Nucl Med"},{"key":"1154_CR17","first-page":"239","volume":"40","author":"RS Liu","year":"1999","unstructured":"Liu RS, Chu LS, Chu YK, Yen SH, Liao SQ, Yeh SH. Does h-oxidation occur in malignant neoplasm? A concurrent [C-11]acetate and [F-18]MISO study (abstract). J Nucl Med 1999;40:239P.","journal-title":"J Nucl Med"},{"key":"1154_CR18","first-page":"2133","volume":"33","author":"PE Valk","year":"1992","unstructured":"Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med 1992;33:2133\u20137.","journal-title":"J Nucl Med"},{"key":"1154_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2307\/3575246","volume":"82","author":"JM Brown","year":"1980","unstructured":"Brown JM, Workman P. Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole. Radiat Res 1980;82:171\u201390. doi: 10.2307\/3575246 .","journal-title":"Radiat Res"},{"key":"1154_CR20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1667\/RR1207.1","volume":"170","author":"SM Evans","year":"2008","unstructured":"Evans SM, Jenkins KW, Jenkins WT, Dilling T, Judy KD, Schrlau A, et al. Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors. Radiat Res 2008;170:677\u201390. doi: 10.1667\/RR1207.1 .","journal-title":"Radiat Res"},{"key":"1154_CR21","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1158\/1078-0432.CCR-04-1081","volume":"10","author":"SM Evans","year":"2004","unstructured":"Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 2004;10:8177\u201384. doi: 10.1158\/1078-0432.CCR-04-1081 .","journal-title":"Clin Cancer Res"},{"key":"1154_CR22","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00259-007-0424-3","volume":"34","author":"M Souvatzoglou","year":"2007","unstructured":"Souvatzoglou M, Grosu AL, Roper B, Krause BJ, Beck R, Reischl G, et al. Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study. Eur J Nucl Med Mol Imaging 2007;34:1566\u201375. doi: 10.1007\/s00259-007-0424-3 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1154_CR23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00259-005-1880-2","volume":"32","author":"RJ Hicks","year":"2005","unstructured":"Hicks RJ, Rischin D, Fisher R, Binns D, Scott AM, Peters LJ. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging 2005;32:1384\u201391. doi: 10.1007\/s00259-005-1880-2 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1154_CR24","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1200\/JCO.2005.05.2878","volume":"24","author":"D Rischin","year":"2006","unstructured":"Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006;24:2098\u2013104. doi: 10.1200\/JCO.2005.05.2878 .","journal-title":"J Clin Oncol"},{"key":"1154_CR25","first-page":"1921","volume":"47","author":"MH Cherk","year":"2006","unstructured":"Cherk MH, Foo SS, Poon AM, Knight SR, Murone C, Papenfuss AT, et al. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-fluoromisonidazole and 18F-FDG PET. J Nucl Med 2006;47:1921\u20136.","journal-title":"J Nucl Med"},{"key":"1154_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2214\/AJR.07.2876","volume":"190","author":"TZ Wong","year":"2008","unstructured":"Wong TZ, Lacy JL, Petry NA, Hawk TC, Sporn TA, Dewhirst MW, et al. PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn\/62Cu generator. AJR Am J Roentgenol 2008;190:427\u201332. doi: 10.2214\/AJR.07.2876 .","journal-title":"AJR Am J Roentgenol"},{"key":"1154_CR27","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1532-5415.2007.01218.x","volume":"55","author":"H Yasuda","year":"2007","unstructured":"Yasuda H, Kaneta T, Takai Y, Nakayama K, Iwata R, Ito M, et al. Tumor hypoxia imaging with [F-18] fluoronitroimidazole in non-small-cell lung cancer. J Am Geriatr Soc 2007;55:1142\u20134. doi: 10.1111\/j.1532-5415.2007.01218.x .","journal-title":"J Am Geriatr Soc"},{"key":"1154_CR28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2967\/jnumed.107.048520","volume":"49","author":"F Dehdashti","year":"2008","unstructured":"Dehdashti F, Grigsby PW, Lewis JS, Laforest R, Siegel BA, Welch MJ. Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med 2008;49:201\u2013205.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1154-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1154-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:01:47Z","timestamp":1558713707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1154-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,9]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1154-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,9]]}}}